Viracta Therapeutics (formerly Sunesis) Revenue and Competitors
Estimated Revenue & Valuation
- Viracta Therapeutics (formerly Sunesis)'s estimated annual revenue is currently $5.9M per year.
- Viracta Therapeutics (formerly Sunesis)'s estimated revenue per employee is $113,269
- Viracta Therapeutics (formerly Sunesis)'s current valuation is $116.8M. (January 2022)
Employee Data
- Viracta Therapeutics (formerly Sunesis) has 52 Employees.
- Viracta Therapeutics (formerly Sunesis) grew their employee count by 30% last year.
Viracta Therapeutics (formerly Sunesis)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | President, CEO | Reveal Email/Phone |
2 | CEO and President | Reveal Email/Phone |
3 | VP, Finance | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | SVP, Regulatory | Reveal Email/Phone |
6 | VP Quality Assurance | Reveal Email/Phone |
7 | SVP, Legal Affairs & General Counsel | Reveal Email/Phone |
8 | VP, Pharmaceutical Development | Reveal Email/Phone |
9 | VP, Portfolio Planning and Program Management | Reveal Email/Phone |
10 | Head Investor Relations & Corporate Communications | Reveal Email/Phone |
Viracta Therapeutics (formerly Sunesis) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Viracta Therapeutics (formerly Sunesis)?
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
keywords:N/A
N/A
Total Funding
52
Number of Employees
$5.9M
Revenue (est)
30%
Employee Growth %
$116.8M
Valuation
N/A
Accelerator
Viracta Therapeutics (formerly Sunesis) News
2022-04-13 - Viracta Therapeutics (NASDAQ:VIRX) Rating Increased to ...
Viracta Therapeutics Inc., formerly known as Sunesis Pharmaceuticals Inc., is based in SAN DIEGO. Get Viracta Therapeutics alerts: Separately,...
Other Companies in Cardiff-by-the-Sea
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 59 | 37% | N/A |
#2 | N/A | 374 | 7% | N/A |